期刊文献+
共找到21篇文章
< 1 2 >
每页显示 20 50 100
锝[^(99m)Tc]放射性药品注射用配套药盒中Sn(II)含量测定方法概述
1
作者 杨佳宁 崔晓艳 +3 位作者 王玉玺 王勇 李岩 杨柳 《同位素》 CAS 2024年第4期399-405,共7页
氯化亚锡的含量是锝[^(99m)Tc]放射性药品注射用配套药盒质量控制的重要指标之一,直接影响锝[^(99m)Tc]放射性药品的临床使用效果,选择合适的分析方法对其进行准确测定至关重要。通过对比《中国药典》2020年版收录的放射性药品质量标准... 氯化亚锡的含量是锝[^(99m)Tc]放射性药品注射用配套药盒质量控制的重要指标之一,直接影响锝[^(99m)Tc]放射性药品的临床使用效果,选择合适的分析方法对其进行准确测定至关重要。通过对比《中国药典》2020年版收录的放射性药品质量标准以及相关文献资料,对常用的氯化亚锡含量测定方法包括电位分析法、分光光度法、高效液相色谱法等的特点、测定原理以及应用进行分析总结,可为建立更科学、合理的锝[^(99m)Tc]放射性药品注射用配套药盒质量标准提供技术参考。 展开更多
关键词 锝[^(99m)Tc]放射性药品注射用配套 氯化亚锡含量测定 电位分析法 分光光度法 高效液相色谱法
下载PDF
外周介入预防性抗生素在放射性药盒导管植入术中的运用
2
作者 Gebauer B Teichgrber U +2 位作者 Werk M Wagner HJ 裴贻刚 《放射学实践》 2007年第12期1343-1343,共1页
关键词 预防性抗生素 导管植入术 放射性药 介入放射 导管相关性感染 单次注射 植入术后 盒导管
下载PDF
放射性新药申报中应注意的若干问题
3
作者 黄天森 《中国药事》 CAS 1992年第3期197-199,共3页
本文根据《新药审批办法》的要求,结合放射性药品的特点,提出了放射性新药申报资料中,应注意的若干问题,其中包括新药的命名、结构的确证、制备工艺、质量研究、安全试验、动物分布及显象、初步稳定性试验、质量标准及起草说明、标签及... 本文根据《新药审批办法》的要求,结合放射性药品的特点,提出了放射性新药申报资料中,应注意的若干问题,其中包括新药的命名、结构的确证、制备工艺、质量研究、安全试验、动物分布及显象、初步稳定性试验、质量标准及起草说明、标签及使用说明书等. 展开更多
关键词 放射性药 申报
下载PDF
用放射性肝胆药物作肝细胞癌阳性显像
4
作者 陈绍亮 赵惠扬 《国外医学(放射医学核医学分册)》 北大核心 1990年第5期230-233,共4页
利用放射性核素肝胆药物作肝细胞癌阳性显像,不仅可作出肝细胞癌(HCC)的定性诊断,同时也具有定位价值.定性阳性率可高达60%,诊断特异性在95%以上.此外,它对寻找HCC肝外转移灶、诊断肝细胞腺瘤均有一定价值.
关键词 放射性肝胆 肝细胞癌 显像 诊断
下载PDF
血栓显像剂^(99m)Tc-SZ-51药盒的制备及对犬肺栓塞模型的显像研究 被引量:4
5
作者 季顺东 方纬 +4 位作者 王锋 刘秀杰 史蓉芳 吴锦昌 阮长耿 《核技术》 CAS CSCD 北大核心 2002年第11期947-951,共5页
研究99mTc标记抗人P -选择素 (P -Selectin)单克隆抗体SZ - 5 1血栓显像药盒的制备方法 ,并观察其在检测肺栓塞及鉴别新鲜和陈旧肺栓塞中的作用。用 2 -亚氨基噻吩盐酸盐 (2 -IT)修饰SZ - 5 1。用99mTc-GH转换络合标记法标记IT -SZ - 5 ... 研究99mTc标记抗人P -选择素 (P -Selectin)单克隆抗体SZ - 5 1血栓显像药盒的制备方法 ,并观察其在检测肺栓塞及鉴别新鲜和陈旧肺栓塞中的作用。用 2 -亚氨基噻吩盐酸盐 (2 -IT)修饰SZ - 5 1。用99mTc-GH转换络合标记法标记IT -SZ - 5 1。分别用快速薄层层析法、酶联免疫吸附法 (ELISA)测定标记物的标记率及生物活性。单抗SZ - 5 1以最佳标记条件制备体内血栓显像药盒 ,对 8只犬肺栓塞模型进行了放射免疫显像。结果表明 ,单抗SZ - 5 1用最佳 2 -IT比例修饰后 ,快速薄层层析法测得标记率为 90 %— 95 %,ELISA表明抗体保留了免疫活性。注入显像剂99mTcSZ - 5 11h后血栓部位开始显影并 3h内逐渐清晰。注射后 3h ,在体显像及离体显像两者的放射性比值分别为 5 .3± 0 .5和 7.0± 1.2 ,形成 1天的新鲜血栓的放射性摄取明显高于形成一周的血栓 ,离体组织测定两者比值达 2 .6 5。 展开更多
关键词 血栓显像剂 ^99mTc-SZ-51 单克隆抗体 肺栓塞 放射免疫显像 动物实验 锝99 放射性核素 放射性药 治疗 诊断
下载PDF
Structural Investigation of Technetium-Diphosphonate Complex 99mTc-MDP
6
作者 邱玲 林建国 +2 位作者 居学海 贡雪东 罗世能 《Chinese Journal of Chemical Physics》 SCIE CAS CSCD 2011年第3期295-304,I0003,共11页
Density functional theory method has been employed to investigate the structures of the prototypical technetium-labeled diphosphonate complex 99mTc-MDP, where MDP represents methylenediphosphonic acid. A total of 14 t... Density functional theory method has been employed to investigate the structures of the prototypical technetium-labeled diphosphonate complex 99mTc-MDP, where MDP represents methylenediphosphonic acid. A total of 14 trial structures were generated by allowing for the geometric, conformational, charge, and spin isomerism. Based on the optimized structures and calculated energies at the B3LYP/LANL2DZ level, two stable isomers were determined for the title complex. And they were further studied systematically in comparison with the experimental structure. The basis sets 6-31G*(LANL2DZ for Tc), 6-31G*(cc-pVDZ-pp for Tc), and DGDZVP have also been employed in combination with the B3LYP functional to study the basis set effect on the geometries of isomers. The optimized structures agree well with the available experimental data, and the bond lengths are more sensitive to the basis set than the bond angles. The charge distributions were studied by the Mulliken population analysis and natural bond orbital analysis. The results reflect a significant ligand-to-metal electron donation. 展开更多
关键词 RADIOPHARMACEUTICAL 99mTc-methylenediphosphonate Structural prediction Density functional theory Basis set effect
下载PDF
紫外分光光度法测定注射用亚锡植酸钠中植酸的含量
7
作者 汪洋 杨敏 胡名扬 《药物分析杂志》 CAS CSCD 北大核心 2001年第2期128-129,共2页
关键词 注射用亚锡植酸钠 植酸 含量测定 紫外分光光度法 放射性诊断 配套
下载PDF
^(153)Sm-EDTMP:有效地治疗骨癌疼痛
8
作者 Richard AH 刘静波 《国外医学(放射医学核医学分册)》 北大核心 1993年第1期30-32,共3页
^(153)Sm-EDTMP试用于转移性骨癌疼痛病人的治疗,估计65.4%的病人疼痛可得到缓解,且只有轻度和短暂的骨髓毒性。为使^(153)Sm-EDTMP获得临床应用,必须进一步研究证明其作为止痛剂的功效,以排除“配体止痛作用”。
关键词 骨肿瘤 疼痛 放射性药 治疗
下载PDF
Pharmacokinetics of Recombinant E. coli L-asparaginase in Rats
9
作者 陈建华 吴梧桐 平野和行 《Journal of Chinese Pharmaceutical Sciences》 CAS 2002年第4期142-147,共6页
The distribution of ^(125)I recombinant E. coli L-asparaginase in tissues ororgans and the excretion in urine, feces and bile were studied with in vivo radioactive tracertechnique. The amount of radioactivity excreted... The distribution of ^(125)I recombinant E. coli L-asparaginase in tissues ororgans and the excretion in urine, feces and bile were studied with in vivo radioactive tracertechnique. The amount of radioactivity excreted in urine, feces and bile within 24 h afterintravenous administration of ^(125)I recombinant E. col L-asparaginase to rats was 68.95% ,4.44%and 5.36% of the dose respectively. ^(125)I recombinant E. coli L-asparaginase in plasma samples wasdetermined. The levels of structural intact molecule in plasma samples were evaluated by SDS-PAGEand bio-imaging analyzer system. Pharmacokinetic parameters were assessed with a model-dependentmethod. The concentration-time curves of recombinant E. coli L-asparaginase after intravenousinjection at 1 250 IU·kg^(-1), 2 500, IU·kg^(-1), 5 000 IU·kg^(-1) to rats were consistent withthe two-compartment model. The first and terminal elimination t_(1/2) were 0.52 ~ 0.63 h and 2.39 ~2.76 h respectively. AUC was linearly related to the doses. The results of distribution in tissuesor organs and excretion in urine suggested that the metabolites of the enzyme were cleared bymechanisms of urinary excretion. Pharmacokinetics parameters of recombinant E. coli L- asparaginasein rats are warranted for the design of future clinical trials. 展开更多
关键词 pecombinant e. coli l- asparaginase PHARMACOKINETICS
下载PDF
Monoclonal immunoscintigraphy for detection of metastasis and recurrence of colorectal cancer 被引量:4
10
作者 Vera Artiko Ana Koljevic Markovi +13 位作者 Dragana obi-aranovi Milorad Petrovi Andrija Anti Mirjana Stojkovi Marinko Zuvela Djordjije aranovi Milica Stojkovi Neboja Radovanovi Danijel Galun Aleksandar Milovanovi Jovica Milovanovi Anica Bobi-Radovanovi Zoran Krivokapic Vladimir Obradovi 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第19期2424-2430,共7页
AIM:To assess the clinical role of monoclonal immunoscintigraphy for the detection of metastasis and recurrence of colorectal cancer.METHODS:Monoclonal immunoscintigraphy was performed in patients operated on for colo... AIM:To assess the clinical role of monoclonal immunoscintigraphy for the detection of metastasis and recurrence of colorectal cancer.METHODS:Monoclonal immunoscintigraphy was performed in patients operated on for colorectal adenocar-cinoma suspected of local recurrence and metastatic disease.The results were compared with conventional diagnostics.RESULTS:Immunoscintigraphic investigation was done in 53 patients.Tumor recurrence occurred in 38 patients,and was confirmed by other diagnostic modalities in 35.In 15 patients,immunoscintigraphic findings were negative,and confirmed in 14 with other diagnostic methods.Comparative analysis confirmed good correlation of immunoscintigraphic findings and the results of conventional diagnostics and the level of tumor marker carcinoembryonic antigen.Statistical analysis of parameters of radiopharmaceutical groups imacis,indimacis and oncoscint presented homogenous characteristics all of three radiopharmaceuticals.The analysis of immunoscintigraphic target focus was clearly improved using tomography.CONCLUSION:Immunoscintigraphy is highly specific and has a good predictive value in local recurrence of colorectal cancer. 展开更多
关键词 IMMUNOSCINTIGRAPHY Monoclonal antibodies Colorectal carcinoma Tumor metastasis Tumor recurrence
下载PDF
PREPARATION OF BONE TUMOR THERAPEUTIC RADIOPHARMACEUTICALS ^(153)Sm-EDTMP 被引量:2
11
作者 罗顺忠 蒲满飞 +4 位作者 谯健 刘中林 赵鹏骥 傅依备 邓侯富 《Nuclear Science and Techniques》 SCIE CAS CSCD 1995年第3期146-149,共4页
Samarium-153- EDTMP (ethylene diamine tetramethylene phosphonate), for its promising biological properties, has been proved as a palliating therapeutic agent for bone tumor in human beings. 153Sin with high radionucl... Samarium-153- EDTMP (ethylene diamine tetramethylene phosphonate), for its promising biological properties, has been proved as a palliating therapeutic agent for bone tumor in human beings. 153Sin with high radionuclear purity and specific activity of 5.18 GBq (140 mCi)/mg Sm2O3 was prepared by irradiating naturalSm2O3(152Sm, 26.7%) sample, replacing costly enriched samarium oxide target, at a flux of 4x 1013n.cm-2.s-1 for 110 h. The yield of 153Sm complexing with EDTMP is greater than 98% at PH 8 ̄10 in boiling water bath for 30 min, and not significantly decreases within one week after 153Sm-EDTMP complex formation. 展开更多
关键词 Bone tumor Therapeutic radiopharmaceuticals 153Sm 153SM-EDTMP
下载PDF
Antioxidant therapy for chronic hepatitis C after failure of interferon:Results of phase Ⅱ randomized,double-blind placebo controlled clinical trial 被引量:2
12
作者 Ezra Gabbay Ehud Zigmond +5 位作者 Orit Pappo Nila Hemed Mina Rowe George Zabrecky Robert Cohen Yaron Ilan 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第40期5317-5323,共7页
AIM: TO assess the safety and efficacy of antioxidant therapy for patients with chronic hepatitis C virus (HCV) infection.METHODS: One hundred chronic HCV infection patients failed in interferon treatment were enr... AIM: TO assess the safety and efficacy of antioxidant therapy for patients with chronic hepatitis C virus (HCV) infection.METHODS: One hundred chronic HCV infection patients failed in interferon treatment were enrolled and randomly assigned to receive combined intravenous and oral antioxidants or placebo, or oral treatment alone, Primary end points were liver enzymes, HCV-RNA levels and histology.RESULTS: Combined oral and intravenous antioxidant therapy was associated with a significant decline in ALT levels in 52% of patients who received antioxidant therapy vs 20% of patients who received placebo (P = 0.05). Histology activity index (HAI) score at the end of treatment was reduced in 48% of patients who received antioxidant therapy vs 26% of patients who received placebo (P = 0.21). HCV-RNA levels decreased by l-log or more in 28% of patients who received antioxidant therapy vs 12% who received placebo (P = NS). In part 11 of the trial, oral administration of antioxidants was not associated with significant alterations in any of the end points.CONCLUSION: Antioxidant therapy has a mild beneficial effect on the inflammatory response of chronic HCV infection patients who are non-responders to interferon. Combined antiviral and antioxidant therapy may be beneficial for these patients. 展开更多
关键词 Hepatitis C virus Antioxidant therapy Histology activity index GLYCYRRHIZA L-g utathione
下载PDF
RADIOIODINATION AND PHARMACOKINETICS OF BIVALENT ANALOG OF PRACTOLOL AS MYOCARDIAL IMAGING AGENT
13
作者 曹国宪 李卫一 +1 位作者 张荣军 俞惠新 《Nuclear Science and Techniques》 SCIE CAS CSCD 1995年第4期238-240,共3页
Solid phase exchange radioiodination method was used to label the compound.Pharmacokinetics was studied in rats and the data were dealt with by computer. The results indicate that the compound would be a potential myo... Solid phase exchange radioiodination method was used to label the compound.Pharmacokinetics was studied in rats and the data were dealt with by computer. The results indicate that the compound would be a potential myocardial imaging agent. 展开更多
关键词 Bivalent analog of practolol RADIOIODINATION PHARMACOKINETICS Myocardial imaging agent  ̄(125)I
下载PDF
A New Method of Producing Radionuclide-Labeled Microspheres for Radionuclide Therapy
14
作者 Aibassov Yerkin Zhakenovich Yemelyanova Valentina Stepanovna Shakieva Tatyana Vladimirovna Tussupbaev Nessipbay Kuandykovich Imanbekov Klysh Bulenbayev Maksat 《Journal of Chemistry and Chemical Engineering》 2014年第9期925-928,共4页
This work is devoted to obtaining radionuclide-labeled microspheres for radionuclide therapy as a therapeutic drug with a selective method of delivery. The nature of magnetic microspheres and quantitative elemental co... This work is devoted to obtaining radionuclide-labeled microspheres for radionuclide therapy as a therapeutic drug with a selective method of delivery. The nature of magnetic microspheres and quantitative elemental composition radiopreparats was considered. We have developed a new method of producing radionuclide-labeled microspheres (radiopharmaceutical ^140Nd-microspheres) for radionuclide therapy. 展开更多
关键词 Radionuclide-labeled microspheres radiopharmaceutica ^140Nd-microspheres radionuclide therapy.
下载PDF
Conceptual Proposal of a Facility Design for Accommodating Minipigs for Pharmaceutical and Radiopharmaceutical Research
15
作者 Elizabeth B. F. Lainetti Luiz Augusto C. Passos +1 位作者 Carlos R. J. Soares Nanci do Nascimento 《Journal of Civil Engineering and Architecture》 2016年第8期881-887,共7页
The use of Animal House Facilities of IPEN-CNEN/SP (Nuclear and Energetic Research Institute-National Nuclear Energy Commission/SP, Brazil) has provided rats and mice with controlled sanitary quality for research an... The use of Animal House Facilities of IPEN-CNEN/SP (Nuclear and Energetic Research Institute-National Nuclear Energy Commission/SP, Brazil) has provided rats and mice with controlled sanitary quality for research and quality control in the production of radiopharmaceuticals lots, produced at IPEN, following rules of CONCEA-Brazilian National Council for Animal Experimentation Control and approved in CEUA (Ethics Committee on the Use of Animals), before they are sent to hospitals and clinics spread out in Brazil, for use in nuclear medicine. The production and the supply of high quality laboratory animals have fundamental importance for the accomplishment of vanguard scientific research, with reproducibility and universality. The quality of those animals depends, largely, on the available facilities for their production and lodging, to assure the demanded sanitary control and animal's welfare, in agreement with the ethical principles that control the activity. Therefore, the facilities design is of vital importance so that the mentioned requirements can be reached. Nevertheless, pigs and miniature pigs have gained importance as large animal models in medicine. With their size, organ capacity, and physiology resembling in several aspects that of humans, pigs are well suited for preclinical experiments and long-term safety studies. Minipigs will be used for preclinical testing of radiopharmaceuticals and assays radioactive materials for cardiac tests. This paper describes the premises and preliminary activities that have been performed at IPEN for the design of new Animal House Facilities dedicated to keeping minipigs taking into account fundamental aspects such as: animal's welfare, sanitation, genetic, in agreement with the ethical principles that control the activity and environmental concerns. 展开更多
关键词 Research animals minipigs HOUSING FACILITY design conceptual proposal.
下载PDF
特殊药品生产管理风险源探查
16
作者 赵冬梅 于丽萍 《首都医药》 2012年第5期30-31,共2页
麻醉药、精神药、医疗用毒性药、放射性药……这些特殊药品(简称"特药")往往与成瘾性和习惯性相联系。如果患者滥用或使用不当,则容易对特药产生药物依赖性,可能对个人、家庭,社会造成严重危害。
关键词 品生产管理 风险 物依赖性 特殊 放射性药 使用不当 麻醉 精神
原文传递
辐射损伤防治药物研究进展
17
作者 杜亚南 杨雪莹 曾强 《中华劳动卫生职业病杂志》 CAS CSCD 北大核心 2023年第3期237-240,共4页
辐射损伤防治药物是指能抑制辐射损伤的发生,或者在照射后早期使用减轻辐射损伤的发展,促进损伤恢复的药物。根据作用机制和干预时间,将辐射损伤的防治药物分为4类,即外辐射暴露的防护药、缓解药、治疗药以及放射性核素内污染防治药。... 辐射损伤防治药物是指能抑制辐射损伤的发生,或者在照射后早期使用减轻辐射损伤的发展,促进损伤恢复的药物。根据作用机制和干预时间,将辐射损伤的防治药物分为4类,即外辐射暴露的防护药、缓解药、治疗药以及放射性核素内污染防治药。本文对近年来辐射损伤防治药的研究进展进行综述。 展开更多
关键词 辐射 电离 辐射损伤 辐射防护剂 辐射损伤缓解 辐射损伤治疗 放射性核素内污染防治
原文传递
应用整体自显影定量技术开展的单多次给药后大鼠组织分布比较研究
18
作者 何隆孟 熊雅婷 +4 位作者 冯浩 喻振文 吴磊 朱轩轩 顾哲明 《中国新药杂志》 CAS CSCD 北大核心 2021年第3期259-266,共8页
目的:应用整体自显影定量技术(QWBA),比较单次和重复多次给药后大鼠体内的组织分布情况,以指导人体放射性物质平衡试验设计。方法:按15 mg·kg^(-1)剂量,分别灌胃给予雄性Long-Evans(LE)大鼠0,7和14次的非放射性标记药物VPS-01(qd) ... 目的:应用整体自显影定量技术(QWBA),比较单次和重复多次给药后大鼠体内的组织分布情况,以指导人体放射性物质平衡试验设计。方法:按15 mg·kg^(-1)剂量,分别灌胃给予雄性Long-Evans(LE)大鼠0,7和14次的非放射性标记药物VPS-01(qd) 24 h后单次灌胃给予100μCi/15 mg·kg^(-1)的[14C]VPS-01(分别定义为0+1,7+1和14+1给药组);于给予放射性标记药物后的3,24,168和504 h每组处死1只大鼠,收集尸体并立即冷冻。使用大型冰冻切片机(Leica CM3600 XP)切片,适当处理后使用磷显像技术获得切片中各组织和感兴趣区域的放射性强度。结果:采用3种不同方式给药后总放射性均广泛分布于各组织中,VPS-01和/或其相关代谢产物与黑色素存在结合的现象。与0+1给药组比,7+1给药组中大鼠各组织放射性浓度及暴露量均显著降低;据大鼠组织暴露量估算的人体单次口服[14C]VPS-01可给予的最大放射性剂量从61.6增加到611μCi。14+1给药组大鼠的组织放射性浓度和暴露量更低,但与7+1组无显著性差异。结论:具有组织共价结合导致体内消除缓慢的药物在物质平衡试验中易引起人体放射性暴露量高,如先重复给予受试者数次非放射性标记药物,待人体内达到稳态后单次给予14C-标记药物,可显著降低受试者辐射暴露、加大人体放射性剂量可选择范围并增加循环血液中放射性浓度而易于代谢产物的鉴定。 展开更多
关键词 整体自显影技术 组织分布 人体放射性剂量 物质平衡
原文传递
Therapeutic radionuclides in nuclear medicine: current and future prospects 被引量:7
19
作者 Chai-Hong YEONG Mu-hua CHENG Kwan-Hoong NG 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2014年第10期845-863,共19页
The potential use of radionuclides in therapy has been recognized for many decades. A number of radionuclides, such as iodine-131(^131I), phosphorous-32(^32P), strontium-90(^90Sr), and yttrium-90(^90Y), have b... The potential use of radionuclides in therapy has been recognized for many decades. A number of radionuclides, such as iodine-131(^131I), phosphorous-32(^32P), strontium-90(^90Sr), and yttrium-90(^90Y), have been used successfully for the treatment of many benign and malignant disorders. Recently, the rapid growth of this branch of nuclear medicine has been stimulated by the introduction of a number of new radionuclides and radiopharmaceuticals for the treatment of metastatic bone pain and neuroendocrine and other malignant or non-malignant tumours. Today, the field of radionuclide therapy is enjoying an exciting phase and is poised for greater growth and development in the coming years. For example, in Asia, the high prevalence of thyroid and liver diseases has prompted many novel developments and clinical trials using targeted radionuclide therapy. This paper reviews the characteristics and clinical applications of the commonly available therapeutic radionuclides, as well as the problems and issues involved in translating novel radionuclides into clinical therapies. 展开更多
关键词 Therapeutic radionuclide Targeted radionuclide therapy RADIOIMMUNOTHERAPY Molecular targeting THERANOSTICS
原文传递
Effects of the Drug(BSZGC)-containing Serum on Proliferation of Rat's Osteoclasts and TRACP Activity in vitro 被引量:1
20
作者 师晶丽 赵永华 +1 位作者 吴伟康 周永生 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2008年第3期211-216,共6页
Objective: To observe effects of the drug-containing serum ofBu Shen Zhuang Gu Capsule (BSZGC 补肾壮骨胶囊 Capsule for Tonifying the Kidney to Strengthen the Bones) on proliferation of the rat's osteoclasts and ta... Objective: To observe effects of the drug-containing serum ofBu Shen Zhuang Gu Capsule (BSZGC 补肾壮骨胶囊 Capsule for Tonifying the Kidney to Strengthen the Bones) on proliferation of the rat's osteoclasts and tartrate-resistant acid phosphatase (TRACP) activity in vitro so as to delve into the mechanisms of its preventive and therapeutic actions on osteoporosis. Methods: Forty female Sprague-Dawley rats aged three months were randomly divided into high dosage BSZGC group, medium dosage BSZGC group, low dosage BSZGC group, and the control group. BSZGC was orally administered into the rats of high, medium, and low dosage groups at different dosages for 12 days, and isometric normal saline was orally administered to the rats of the control group. The drug-containing serum and control serum were prepared. Osteoclasts isolated mechanically from the femur and tibia of Sprague-Dawley rats aged one week were cultured with medium added with different drug-containing sera and control serum. The growth of osteoclasts was observed under an inverted phase-contrast microscope, and optic density (OD) value of osteoclasts was determined by MTT colorimetric assay. TRACP activity was measured by the diazol method. Results: OD value of osteoclasts in the high dosage drug-containing serum group, medium dosage drug-containing serum group, and low dosage drug-containing serum group was significantly lower than that in the control serum group (P〈0.05) with a dose-effect correlation. TRACP activity in high dosage drug-containing serum group, medium dosage drug-containing serum group, low dosage drug-containing serum group was significantly lower than that of the control serum group (P〈0.01), and no significant differences in TRACP activity were not found among the different dosages drug-containing serum groups. Conclusions: BSZGC can inhibit the proliferation of the osteoclasts and reduce TRACP activity, which may be one of the mechanisms of its preventive and theraoeutic actions on osteooorosis. 展开更多
关键词 Bu Shen Zhuang Gu Capsule (BSZGC) OSTEOCLAST Tartrate-resistant acid phosphatase Drug-containing serum
原文传递
上一页 1 2 下一页 到第
使用帮助 返回顶部